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Colon cancerDiet has a signiﬁcant impact on colorectal cancer and both dietary ﬁber and plant-derived compounds have been
independently shown to be inversely related to colon cancer risk. Butyrate (NaB), one of the principal products of
dietary ﬁber fermentation, induces differentiation of colon cancer cell lines by inhibiting histone deacetylases
(HDACs). On the other hand, (−)-epicatechin (EC) and (−)-epigallocatechin gallate (EGCG), two abundant phe-
nolic compounds of green tea, have been shown to exhibit antitumoral properties. In this study we used colon
cancer cell lines to study the cellular and molecular events that take place during co-treatment with NaB, EC
and EGCG. We found that (i) polyphenols EC and EGCG fail to induce differentiation of colon adenocarcinoma
cell lines; (ii) polyphenols EC and EGCG reduce NaB-induced differentiation; (iii) the effect of the polyphenols
is speciﬁc for NaB, since differentiation induced by other agents, such as trichostatin A (TSA), was unaltered
upon EC and EGCG treatment, and (iv) is independent of the HDAC inhibitory activity of NaB. Also, (v) polyphe-
nols partially reduce cellular NaB; and (vi) on a molecular level, reduction of cellular NaB uptake by polyphenols
is achieved by impairing the capacity of NaB to relocalize its own transporter (monocarboxylate transporter 1,
MCT1) in the plasma membrane. Our ﬁndings suggest that beneﬁcial effects of NaB on colorectal cancer may
be reduced by green tea phenolic supplementation. This valuable information should be of assistance in choosing
a rational design for more effective diet-driven therapeutic interventions in the prevention or treatment of colo-
rectal cancer.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Colorectal cancer constitutes one of the most frequent malignancies
worldwide and is one of the prevalent causes of cancer-related mortal-
ity in the western world [1]. Therefore, further development of thera-
peutic and preventive approaches to control this disease is clearly
needed. A diet rich in ﬁber and plant-derived compounds present in
tea, fruits and vegetables has been inversely associated with the risk
of colorectal cancer [2,3]. Furthermore, theprotective effect of the bioac-
tive compounds present in these dietary constituents has been shown
to be related to the activity of human intestinal microbiota. In thiste; EC, (−)-epicatechin; EGCG,
MCT1, monocarboxylate trans-
nyltetrazolium bromide; TSA,
istry and Molecular Biology,
nal 643 (Prevosti p-2), 08028
, Pedro.Vizan@crg.eu (P. Vizán),
J.J. Centelles),
ights reserved.regard, consumption of natural phenolics has been shown to increasemi-
crobial fermentation products such as butyrate (NaB— sodium butyrate)
from dietary ﬁber [4–6], thereby providing a beneﬁcial effect to the host.
However, themechanism bywhich NaB and phenolics interact at the cel-
lular level has not been satisfactorily addressed.
NaB has been described as a potent antitumoral agent against colon
cancer, and has been used in clinical trials for treating cancers [7]. NaB is
a four-carbon fatty acid that represents amajor oxidative fuel for colonic
epithelial cells [8]. Previous studies have demonstrated that deﬁciency
in the availability or utilization of NaB causes colitis and may be in-
volved in ulcerative colitis and colon carcinogenesis [9,10]. Moreover,
NaB induces apoptosis and cell cycle arrest in the G1/G0 phase, accom-
panied by terminal cell differentiation in several colon cancer cell lines
[11–13]. The mechanism by which NaB induces differentiation primar-
ily involves epigenetic regulation of gene expression through the inhibi-
tion of histone deacetylases (HDACs) [14], which remove acetyl groups
from lysine residues of histones and decrease the afﬁnity of protein
transcription complexes for DNA.
Numerous studies have evaluated the antitumor activities of green
tea phenolics in different experimental systems. The general consensus
is that these tea components promote cancer cell growth inhibition and
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plethora of molecular mechanisms of tea phenolics has been suggested,
including anti-oxidant and pro-oxidant effects, inhibition of mitogen-
activated protein kinases, or modulation of growth factor receptor tyro-
sine kinases and the activity of transporters through alteration of lipid
rafts by tea catechins (reviewed in Ref. [16]).
The effect of green tea catechins on differentiation has been addressed
in several cell lines [17–19], including colon cancer cells [20], in which
their effects appear to be cell line-speciﬁc. Moreover, a recent study has
investigated the impact of green tea phenolics onNaB-induced colon can-
cer cells differentiation and concluded that changes in NaB uptake in
Caco2 cells induced by phenolics do not correlate with changes upon
cell differentiation [21]. In the present study we evaluated the effect of
the major green tea phenolics (−)-epigallocatechin gallate (EGCG) and
(−)-epicatechin (EC) on NaB-induced differentiation in human colon ad-
enocarcinoma HT29 cells. We demonstrate that phenolics interfere with
NaB induced differentiation, andwe propose amechanism for this inhibi-
tion based on the altered localization of amonocarboxylate transporter in
plasma membrane lipid rafts.
2. Materials and methods
2.1. Chemicals and cell culture conditions
All chemicalswere purchased fromSigma-Aldrich Co. (St. Louis,MO),
unless otherwise speciﬁed. HT29 human colon adenocarcinoma cells
(obtained from the American Type Culture Collection) were grown in
Dulbecco's modiﬁed Eagle medium 25 mM D-glucose supplemented
with 10% heat-inactivated fetal calf serum (PAA Laboratories, Pasching,
Austria) and 0.1% antibiotics (100 U/mL penicillin and 100 μg/mL strep-
tomycin) (Invitrogen, Paisley, UK). Caco2 cells were maintained in
Dulbecco's modiﬁed Eagle medium 25 mM D-glucose, 20% fetal calf
serum, 2 mM glutamine, and 1% antibiotics (100 U/mL penicillin and
100 μg/mL streptomycin). NCM460 (INCELL Corporation, San Antonio,
Texas, USA) is an epithelial cell line derived from the healthy colon mu-
cosa of a 68-year-old Hispanic male [22]. These cells were grown as a
monolayer culture in M3Base medium (which contains growth supple-
ments and antibiotics) supplemented with 10% heat-inactivated FCS
and 2.5 mM of D-glucose. Cells were cultured at 37 °C in a humidiﬁed
atmosphere with 5% CO2.
2.2. Determination of cell viability
Assays were performed using a variation of theMTT assay described
by Mosmann [23]. HT29 cells were seeded at 3 × 103 cells/well in 96-
well ﬂat-bottom plates. After 24 h of incubation at 37 °C, fresh media
containing (−)-epicatechin (EC) and (−)-epigallocatechin gallate
(EGCG) at different concentrations were added. After 72 h, the media
was removed, and 50 μL of MTT (1 mg/mL in phosphate buffered sa-
line) with 50 μL of freshmediumwas added to eachwell and incubated
for 1 h. The MTT reduced to blue formazan and the precipitate was
dissolved in 100 μL of dimethyl sulfoxide. Absorbance valuesweremea-
sured on an ELISA plate reader (550 nm) (Tecan Sunrise MR20-301,
Tecan, Salzburg, Austria).
2.3. Alkaline phosphatase (AP) activity assay
AP activity was measured using p-nitrophenyl phosphate as a sub-
strate according to the published procedures [24]. HT29 cell cultures
were started with 6 × 105 in 60-cm2 petri dishes and incubated for
24 h at 37 °C. New medium containing phenolics, butyrate (NaB) and
NaB + phenolics was added and incubated for 24, 48 and/or 72 h at
37 °C. The medium was changed every 24 h. After incubation, the cells
were washed with phosphate buffered saline (PBS), detached from the
ﬂasks using 0.025% trypsin-EDTA (Invitrogen) and then resuspended
in lysis buffer (1 mM dithiothreitol, 1 mM EDTA, 0.02% Triton X-100,0.02% sodium deoxycholate, 0.2 mM phenylmethylsulfonyl ﬂuoride,
1% sodium azide and 20 mMTris-HCl, pH 7.5). Cells were homogenized
using a laboratory sonicator (1/2 Liter Branson 200 Ultrasonic bath,
5 min, 40 kHz, 4 °C) and immediately ultracentrifuged at 105,000 ×g
for 1 h at 4 °C. The supernatant was separated and used for the determi-
nation of AP activity using a CobasMira Plus chemistry analyzer (HORIBA
ABX, Montpellier, France). The enzyme activity was estimated by mea-
suring the absorbance at 405 nm due to formation of p-nitrophenol
and was expressed as mU/mg of protein. Protein determination was
performed in the same lysates using the BCA protein assay (Pierce Bio-
technology, Rockford, IL).
2.4. Histone deacetylase (HDAC) assay
HT29 cells were incubated in 60-cm2 petri dishes for 48–72 h at 37 °C
(65–85% conﬂuence). Next, cells were washed in PBS pH 7.4 followed by
incubation in hypotonic buffer (20 mM HEPES pH 7.6, 20% glycerol,
10 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.1% Triton X-100) for
5 min. Then, cells were collected and nuclei pelleted at 1000 rpm in the
microfuge for 10 min. Puriﬁed nuclei were resuspended in hypertonic
buffer (20 mM HEPES pH 7.6, 20% glycerol, 450 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.1% Triton X-100) and gently shaken for 1 h at
4 °C. After centrifuging at 13,000 rpm in the microfuge for 5 min at
4 °C, the supernatant obtainedwas thenuclear extract. Then, nuclear ex-
tracts of non-treated HT29 cells were quantiﬁed using a standard BCA
Protein Assay (Pierce Biotechnology, Rockford, IL) and an equivalent
quantity of protein was subjected to treatment with NaB and NaB/
phenolics for 30 min at 37 °C. HDAC activity was measured employing
a Fluorometric Assay Kit (Biovision), following manufacturer's instruc-
tions. The procedure involves the use of the HDAC substrate, which
consists of an acetylated lysine side chain, and incubation with a sample
containing nuclear extract. Deacetylation sensitizes the substrate,
and treatment with the lysine developer produces a ﬂuorophore,
which can be analyzed with a ﬂuorometer (Ex/Em = 350 − 380/
440 − 460 nm). A HeLa cell nuclear extract was used as a positive con-
trol. Percent inhibition of treated cells was compared with HT29
untreated controls.
2.5. [14C]-NaB uptake
HT29 cells were seeded at 2 × 104 cells/well in 24-well plates.
After 24 h of incubation at 37 °C, fresh media containing NaB and
NaB + phenolics was added and incubated for 48 h at 37 °C. Themedi-
umwas changed after 24 h of incubation and left 24 hmore. Next, cells
were incubated at room temperature for 20 min in tracer-free buffer
containing (in mM): 110 NaCl, 1 CaCl2, 4 KCl, 0.44 K2HPO4, 1 MgSO4, 5
glucose, 50 mannitol and 5 HEPES, pH 7.4. Cells were then washed
and incubated with buffer containing (in mM): 259 mannitol, 20
HEPES, pH 6.5, 2 [14C]-NaB (1 μCi/mL) for 5 min. The uptake was
stopped by washing the cells twice with ice-cold PBS. Finally, cells
were solubilized with 0.5 N NaOH for at least 4 h. The protein concen-
tration wasmeasured by the method of BCA. Incorporated radioactivity
was counted by a Tri-CARB 1600-TR liquid scintillation counter
(Packard Instruments, Downers Grove, IL). The values were expressed
as nmol/mg protein/5 min.
2.6. Cell lysates and Western blotting
6 × 105HT29 cellswere plated on60-cm2 petri dishes and incubated
for 24 h. Then, freshmediumwithNaB andNaB + phenolicswas added
and incubated for 48 h. After incubation, the cellswerewashedwith ice-
cold PBS and lysed in 20 mM Tris·HCl, pH 7.5, 150 mM NaCl, 1% Triton
X-100, 1 mM EDTA, 1 mM EGTA, and 1× complete protease inhibitor
cocktail. The lysate was sonicated and centrifuged at 5,000 ×g for
5 min at 4 °C, and protein concentration was determined by Bradford.
The samples obtained above were subjected to 10% SDS–PAGE and
Fig. 1. Dose–effect curves of (−)-epicatechin and (−)-epigallocatechin gallate on cell vi-
ability. HT29 cell cultures were treated with increasing doses of (−)-epicatechin (EC)
(A) or (−)-epigallocatechin gallate (EGCG) (B) as indicated on the x axis for 72 h. Cell
viability was expressed as a percentage with respect to untreated control. IC20 (EC) =
100 μM and IC20 (EGCG) = 20 μM.
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ed utilizing human anti MCT1 antibody (Santa Cruz Biotechnology, sc-
50324). Flotillin expression was analyzed using human anti ﬂotillin
antibody (BD Transduction Laboratories, 610820). β-Actin was used as
a loading control (MP Biomedicals, Eschwege, Germany, 69100).
2.7. Rafts isolation and biochemical characterization
Lipid rafts were isolated by ﬂoatation on OptiPrep density gradient
as previously described [25]. HT29 human colon adenocarcinoma cells
were started in 60-cm2 petri dishes with the same number of cells
(6 × 105) and incubated for 24 h at 37 °C. Then, cells were exposed to
or not exposed to NaB or NaB + phenolics for 48 h. After incubation,
cells were resuspended and incubated for 30 min at 4 °C in TNE buffer
containing (in mM) 25 Tris (pH 7.4), 150 NaCl, 5 EDTA, and 1% Triton
X-100 supplemented with 1× complete protease inhibitor cocktail.
The membranes were then adjusted to 40% ﬁnal concentration of
OptiPrep and layered at the bottom of density gradient with steps of
ﬁnal concentrations of 35, 30, 25, and 20% of OptiPrep in TNE buffer.
TNE buffer was laid on the top of the gradient, which was then centri-
fuged at 48,000 rpm for 4 h at 4 °C. Fractions of 1 mL were collected
from the top to the bottom of the gradient and then analyzed byWest-
ern blotting (see above). MCT1 and the described marker for lipid rafts,
ﬂotillin, were analyzed in each fraction [26].
2.8. Data presentation and statistical analysis
Data are given as the means ± S.D. (standard deviation). For each
assay, the parametric unpaired two-tailed independent sample t-test
was used and differences were considered to be signiﬁcant when
p b 0.05 or p b 0.001.
3. Results
3.1. Viability of HT29 cells treated with (−)-epicatechin (EC) and
(−)-epigallocatechin gallate (EGCG)
To determine a non-toxic but still active concentration of EC and
EGCG, HT29 cell viability was determined in the presence of different
phenolic concentrations (Fig. 1). From the obtained dose-viability
curve we estimated the inhibitory concentration 20 (IC20), deﬁned as
the concentration of product that causes 20% inhibition of cell viability
with respect to viability of control (non-treated) cells after 72 h. Al-
though increasing concentrations of both EC and EGCG produced a
dose-dependent decrease in cell viability, EGCG was much more efﬁ-
cient at doing so. The 72 h IC20 values obtained were 100 μM for EC
and 20 μM for EGCG, which were the concentrations used throughout
the study.
3.2. Phenolics reduce butyrate (NaB)-induced differentiation in colorectal
adenocarcinoma cell lines
Firstly, we studied whether EC and EGCG affected NaB-induced dif-
ferentiation. Cells were exposed to 2 mM NaB for 24, 48 and 72 h,
alone or in the presence of 100 μMEC or 20 μMEGCG. NaB-induced dif-
ferentiationmeasured as an increase in alkaline phosphatase (AP) activ-
ity, was reduced by both phenolics at 48 and 72 h of combined
treatment (Fig. 2A). EC also reduced NaB-induced AP activity at 24 h
(Fig. 2A). It should be noted that treatments with phenolics alone had
no impact on differentiation (Fig. 2B). To rule out a direct effect of the
phenolics on AP activity, we repeated the experiments measuring the
activity of another differentiation marker (aminopeptidase N) at 48 h.
Consistently, phenolics reduced NaB-induced differentiation (Supple-
mental Fig. 1A) and did not show an increase in differentiation when
used alone (Supplemental Fig. 1B). This effect of phenolics was also ex-
tended to another epithelial colorectal adenocarcinoma cell line, Caco2,which showed the same differentiation proﬁle with respect to NaB and
phenolics treatment (Supplemental Fig. 2A and B).
To verifywhether our observationswere cancer cell line-speciﬁc,we
determined NCM460 cell differentiation, measured as AP activity, after
incubation with 2 mM NaB, alone or in the presence of 100 μM EC or
20 μM EGCG, for 24, 48 and 72 h. Supplemental Fig. 3 shows that cell
differentiation was not signiﬁcantly altered when NCM460 cells were
treated with NaB and phenolics.
3.3. The effect of tea phenolics on differentiation is not related to histone
deacetylase (HDAC) activity modulation
Given that the NaB-induced differentiation is related to its inhibition
of HDAC activity [27], we decided to study the effects of EC and EGCG in
HDAC-related differentiation. Firstly, we studied whether phenolics
modiﬁed differentiation induced by trichostatin A (TSA), another well-
described HDAC inhibitor. HT29 cells were exposed to 180 nM TSA for
48 h, alone or in presence of 100 μM EC and 20 μM EGCG. The addition
of phenolics to TSA had no impact on TSA-induced differentiation, mea-
sured as AP activity (Fig. 3A).
To conﬁrm these results, we wondered whether phenolic com-
pounds could directly alter the HDAC activity of HT29. We determined
theHDAC activity of nuclear extracts after incubationwithNaBandphe-
nolics alone or in combination. As expected, NaB was found to be a po-
tent HDAC inhibitor, signiﬁcantly decreasing HDAC activity by 55% and
67% at 500 μM and 2 mM of NaB, respectively (Fig. 3B). Phenolics had
no effect with respect to HDAC activity, both when incubated alone
(Fig. 3B) and incubated simultaneously with NaB (Fig. 3C). These results
Fig. 2. Phenolics reduce butyrate-induced differentiation. (A) HT29 cells were treated with butyrate (NaB) 2 mM or with NaB and phenolics (EC 100 μM and EGCG 20 μM) for 24, 48 and
72 h and alkaline phosphatase (AP) activity wasmeasured and normalized by protein level. The data are normalized and statistically testedwith respect to NaB-treated cells. Mean ± SD;
n ≥ 3; **Different fromNaB, p b 0.01. (B) HT29 cellswere treatedwith NaB2 mMorwith phenolics alone (EC 100 μMand EGCG20 μM) for 24, 48 and72 h andAP activitywasmeasured.
The data are normalized and statistically tested with respect to Ctrl cells. Values are mean ± SD; n ≥ 3; */**Different from Ctrl, p b 0.05/p b 0.01.
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rectly modulating HDAC activity.
3.4. Phenolics impair NaB entry to the cell
To study themechanism of interference between NaB and phenolics
we studied the cellular entry of NaB into HT29 cells. HT29 cells were in-
cubated with 2 mM NaB alone or in the presence of 100 μM EC and
20 μMEGCG for 48 h and acute [14C]-NaB incorporation wasmeasured.
We observed that NaB treatment enhanced its own transport (Fig. 4).
Moreover, we detected a signiﬁcant decrease in [14C]-NaB cellular
entry after NaB and phenolics incubation relative to NaB-treated cells
(Fig. 4).
3.5. The effect of tea phenolics onNaB-induced differentiation is not related to
monocarboxylate transporter 1 (MCT1) expression, but with its membrane
localization
Next, we evaluated the role of the intestinal transporter MCT1,
which is known to be involved in NaB transport [28]. We examined
MCT1 protein expression in response to NaB and phenolics. Western
blot analysis of MCT1 showed no differences at protein level in any of
the treatments (Fig. 5A).
Since phenolics have been shown to be lipid raft regulators [29], we
next investigatedwhether EC and EGCG caused any alterations in the as-
sociation ofMCT1with lipid rafts. Lipid raft microdomains were isolated
by OptiPrep gradient ultracentrifugation and proteins in the gradient
fractions were analyzed by SDS–PAGE and Western blot. Flotillin rich
fractions account for the lipid rafts. As shown in Fig. 5B, MCT1 was pre-
dominantly expressed in these high-density non-raft fractions of control
HT29 cells, even though someMCT1 expressionwas found in lipid rafts-
corresponding fractions. NaB treatment for 48 h enhanced the presenceof MCT1 in low-density fractions representing lipid rafts. When phe-
nolics were added to NaB, MCT1 was redistributed in all fractions,
counteracting NaB-mediated enhanced localization of the transporter
in the lipid rafts (Fig. 5B).
4. Discussion
In this study we analyzed the effect of phenolics (−)-epicatechin
(EC) and (−)-epigallocatechin gallate (EGCG) on butyrate (NaB)-
induced differentiation. We decided to use the IC20 concentrations at
72 h (EC: 100 μM, EGCG: 20 μM) to avoid massive cell damage by phe-
nolics. We used a NaB concentration of 2 mM, which has been demon-
strated to induce differentiation inHT29 colon cancer cells [9]. Although
treatment with EC and EGCG alone did not change cell differentiation,
NaB-induced differentiation was reduced by both phenolics in colon
cancer cells (Fig. 2, Supplemental Fig. 1, Supplemental Fig. 2). In con-
trast, previous studies using colon cancer Caco2 cells showed that
ECGC was not able to revert the differentiation induced by NaB [21].
This discrepancy could be explained because a larger concentration of
NaB (5 mM) and lower concentrations of EGCG (0.1–10 μM) were
used. Worthy of note, since NaB effects were not exerted on the non-
tumoral NCM460 cells (Supplemental Fig. 3), the observed effects are
cancer cell speciﬁc.
The mechanism of action of NaB in colon cancer mainly includes
effects on differentiation via its inhibition of histone deacetylases
(HDACs). EGCG has also been identiﬁed as an inhibitor of HDAC activity
in prostate, skin and breast cancer cells [30]. However, studies in HT29
cells have found no signiﬁcant change in the HDAC activity of cytoplas-
mic or nuclear fractions after sulforaphane and EGCG treatment [31].
Similarly, we also failed to detect any signiﬁcant inhibition of HDAC ac-
tivity in vitro by EC and EGCG (Fig. 3B), and differentiation was not im-
paired in response to treatment with trichostatin A (TSA) (Fig. 3A),
Fig. 3. Phenolics effect on differentiation is not histone deacetylase-related. (A) HT29 cells were treated with TSA at 180 nM or with TSA in the presence of phenolics (EC 100 μM
and EGCG 20 μM) for 48 h and AP activity was measured. Data are normalized and statistically tested with respect to TSA-treated cells. Mean ± SD; n = 3; **Different from TSA,
p b 0.01. (B) Histone deacetylase (HDAC) activity determined in nuclear extracts from HT29 cells after treatment with NaB or NaB with phenolics for 30 min. The data are nor-
malized and statistically tested with respect to Ctrl cells. Values are mean ± SD; n ≥ 2; **Different from Ctrl, p b 0.01. (C) HDAC activity determined in nuclear extracts from
HT29 cells after treatment with NaB or phenolics for 30 min. The data are normalized and statistically tested with respect to NaB cells. Mean ± SD; n ≥ 2; **Different from
NaB, p b 0.01.
Fig. 4. Phenolics impair NaB inﬂux into the cells. HT29 cells were treated with NaB 2 mM
or with NaB and phenolics (EC 100 μM or EGCG 20 μM) for 48 h. Acute [14C]-NaB uptake
was subsequently measured as described in Materials and methods. Results are normal-
ized and statistically tested with respect to NaB cells. Values are mean ± SD; n ≥ 2;
**Different from NaB, p b 0.01.
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[32].
The effect of phenolics on NaB-induced differentiation could be due
to an interaction between NaB and phenolics that prevents the entry
and cellular action of NaB. Determination of [14C]-NaB uptake showed
that although NaB treatment stimulated its own transport, phenolic
treatment impaired NaB uptake (Fig. 4). It has been previously reported
that phenolics differentially affect NaB uptake depending on the studied
compound, the time of incubation and the NaB concentration used.
Nevertheless, on the contrary to our observations, the differences in
NaB uptake induced by phenolics did not correlate with changes in
the anticarcinogenic activity including effects on cell differentiation
[21].
The impairment of NaB uptake by phenolics led us to studyNaB intes-
tinal transporters. NaB enters into colonocytes by two major carrier-
mediated mechanisms, the Na+-coupled monocarboxylate transporter
1 (SMCT1) and the aforementioned H+-coupled monocarboxylate
Fig. 5. Effect of NaB and phenolics on monocarboxylate transporter 1 (MCT1). (A) After
48 h of incubation with NaB, phenolics or both, HT29 lysates were probed against MCT1
in a Western blot, using β-actin as a loading control. A representative blot is shown. (B)
EC and EGCG antagonize plasma membrane redistribution of MCT1 caused by NaB.
HT29 cells were incubated with NaB or NaB/phenolics for 48 h and then lysed and laid
at the bottom of an OptiPrep density gradient. After ultracentrifugation, fractions were
collected from the top (lipid rafts low-density fractions) to the bottom of the gradient
(high-density non-raft fractions). Proteins in the fractions were separated on 10% SDS–
PAGE and blots were probed with anti-MCT1 or anti-ﬂotillin antibodies.
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colon carcinogenesis, both transporters have been proposed to function
as tumor suppressors [33]. Accordingly, MCT1 expression has been
shown to be down-regulated during transition from normalcy to malig-
nancy in colonic tissues. Regarding SMCT1 expression, it has been found
to be silenced in colorectal carcinoma and colon cancer cell lines such as
HT29 and Caco2 [34]. Moreover, given that some phenolics have been
described to interplay withMCT1 [35–38], the next step was the evalua-
tion of MCT1 expression. A substrate-induced MCT1 activity by NaB at
higher concentrations has been previously demonstrated in AA/C1
human colonic epithelial cells [39] and colon cancer Caco2 cells [40].
However, no change inMCT1 protein levels was induced by NaB, pheno-
lics, or both (Fig. 5A).
Since we did not detect an enhanced MCT1 protein, we investigated
the possibility of another mechanism to explain the effects of phenolics
on NaB-induced differentiation. This mechanism may imply alterations
in transduction pathways or cellular membrane characteristics that af-
fect the intrinsic activity of the transporter [21]. Recent reports have in-
dicated that optimal function of many transporters is dependent on
their association with lipid rafts [41]. Lipid rafts are deﬁned as
microdomains within the lipid bilayer of cellular membranes that as-
semble subsets of transmembrane or glycosylphosphatidylinisotol-
anchored proteins and lipids (cholesterol and sphingolipids) and exper-
imentally resist extraction in cold detergent. Interestingly, lipid rafts
have been related to some of the biological effects induced by tea
phenolics [42]. EGCG has been shown to prevent activation of c-Met re-
ceptor [43] and epidermal growth factor receptor (EGFR) [44] via per-
turbations of the membrane lipid rafts. Similarly, our analysis of lipid
raft-dependentMCT1 function in HT29 cells suggests that NaB activatesMCT1 functions at least in part by enhancing its distribution in lipid
rafts, and that tea phenolics produce a redistribution of MCT1 in the
non-lipid raft fractions (Fig. 5B). These observations led us to hypothe-
size that EGCG and EC might inhibit MCT1-mediated NaB transport by
altering lipid raft organization. At the same time, this provides an expla-
nation for the observed increase in NaB uptake after NaB treatment
(Fig. 4), which could not be explained by changes in the quantity of
MCT1 (Fig. 5A), but due to the modulation of lipid rafts by 2 mM NaB
(Fig. 5B).
It has been shown that the chemical structure of phenolics is related
to their biological activity [45]. In green tea catechins, themost bioactive
catechin has been described to be EGCG, which contains a trihydroxyl
structure in the D ring (gallate) as well as a pyrogallol B-ring, followed
closely by ECG with a gallate group, and then to a lesser extent EGC
and EC that possess a basic structure [46]. We have observed that al-
though the global trend of EC and EGCG treatments is similar, small
changes regarding the efﬁciency of both compounds can be distin-
guished. Apart from differences in the chemical structure, differences
in the modulation of signal transduction pathways that affect the activ-
ity of the transporter or the process of differentiation may also account
for the differences observed throughout the study.
As previously mentioned, several studies (4–6) have described an
increase in cecal concentration of short chain fatty acids in response
to phenolics. However, the mechanism by which phenolics induce this
increase is not known. First of all, we hypothesize thatmodulation of in-
testinal microbiota by phenolics to increase production of fermentation
products, such as NaB, might compensate the inhibition of cellular NaB
uptake described in this study. On the other hand, we propose that the
increase in intestinal NaB concentration found in previous studies may
be, at least in part, a consequence of the inhibitory action of phenolics
on NaB intestinal uptake.
5. Conclusions
The present study provides novel evidence that the tea phenolics EC
and EGCG impair NaBuptake and the subsequentNaB-induced differen-
tiation in HT29 cells. These novel ﬁndings suggest that although both
NaB and green tea catechins have been reported to have a wide range
of beneﬁcial effects for human health, when used in tandem the func-
tions of the two compounds interfere at a cellular level. This suggests
that NaB and green tea catechins should be used separately. Further
studies may be required to investigate the physiological signiﬁcance of
our ﬁndings, which provides a better understanding about the interac-
tions of prebiotics andmay aid in preparing a rational design for preven-
tive and therapeutic interventions.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2013.08.009.
Conﬂict of interest
The authors declare that they have no conﬂict of interest.
Acknowledgements
The authors thank Ursula Valls Benavides, Marta Camps Camprubí,
Mireia Pérez Verdaguer and Anna Oliveras Martínez for technical sup-
port in the experiments and all Pradeep K. Dudeja lab members, espe-
cially Arivarasu N. Anbazhagan, for help and support during the stay in
their city and laboratory. Funding was provided by Spanish government
(grants SAF2011-25726, AGL200912374-C03-03/ALI andpersonalﬁnan-
cial support-FPU program); Spanish Networks RTICC RD06/0020/0046;
AGAUR—Generalitat de Catalunya (grants 2009SGR1308 and Icrea Aca-
demia award 2010 to M.C.); NIDDK grants DK54016, DK81858 and
DK92441; and European Commission (FP7) (ETHERPATHS KBBE-grant
agreement 222639 and COSMOS KBBE-grant agreement 312941).
2270 S. Sánchez-Tena et al. / Biochimica et Biophysica Acta 1832 (2013) 2264–2270References
[1] A. Jemal, M.M. Center, C. DeSantis, E.M. Ward, Global patterns of cancer incidence
and mortality rates and trends, Cancer Epidemiol. Biomarkers Prev. 19 (2010)
1893–1907.
[2] A.J. Watson, P.D. Collins, Colon cancer: a civilization disorder, Digest. Dis. (Basel,
Switzerland) 29 (2011) 222–228.
[3] L.R. Ferguson, R.R. Chavan, P.J. Harris, Changing concepts of dietary ﬁber: implica-
tions for carcinogenesis, Nutr. Cancer 39 (2001) 155–169.
[4] J. Juskiewicz, J. Milala, A. Jurgonski, B. Krol, Z. Zdunczyk, Consumption of polyphenol
concentrate with dietary fructo-oligosaccharides enhances cecal metabolism of
quercetin glycosides in rats, Nutrition (Burbank Los Angeles County, Calif) 27
(2011) 351–357.
[5] M. Kosmala, K. Kolodziejczyk, Z. Zdunczyk, J. Juskiewicz, D. Boros, Chemical compo-
sition of natural and polyphenol-free apple pomace and the effect of this dietary in-
gredient on intestinal fermentation and serum lipid parameters in rats, J. Agric. Food
Chem. 59 (2011) 9177–9185.
[6] J. Juskiewicz, E. Zary-Sikorska, Z. Zdunczyk, B. Krol, J. Jaroslawska, A. Jurgonski, Effect
of dietary supplementation with unprocessed and ethanol-extracted apple pomaces
on caecal fermentation, antioxidant and blood biomarkers in rats, Br. J. Nutr. 107
(2012) 1138–1146.
[7] R. Berni Canani, M. Di Costanzo, L. Leone, The epigenetic effects of butyrate: poten-
tial therapeutic implications for clinical practice, Clin. Epigenetics 4 (2012) 4.
[8] B.M. Corfe, E.A. Williams, J.P. Bury, S.A. Riley, L.J. Croucher, D.Y. Lai, C.A. Evans, A
study protocol to investigate the relationship between dietary ﬁbre intake and fer-
mentation, colon cell turnover, global protein acetylation and early carcinogenesis:
the FACT study, BMC Cancer 9 (2009) 332.
[9] G. Alcarraz-Vizan, J. Boren, W.N. Lee, M. Cascante, Histone deacetylase inhibition
results in a common metabolic proﬁle associated with HT29 differentiation,
Metabolomics 6 (2010) 229–237.
[10] J. Boren,W.N. Lee, S. Bassilian, J.J. Centelles, S. Lim, S. Ahmed, L.G. Boros, M. Cascante,
The stable isotope-based dynamic metabolic proﬁle of butyrate-induced HT29 cell
differentiation, J. Biol. Chem. 278 (2003) 28395–28402.
[11] M. Andriamihaja, C. Chaumontet, D. Tome, F. Blachier, Butyrate metabolism in
human colon carcinoma cells: implications concerning its growth-inhibitory effect,
J. Cell. Physiol. 218 (2009) 58–65.
[12] W.J. Shen, D.Q. Dai, Y. Teng, J. Liu, Effects of sodium butyrate on proliferation of
human gastric cancer cells and expression of p16 gene, Zhonghua yi xue za zhi 88
(2008) 1192–1196.
[13] K.J. Humphreys, L. Cobiac, R.K. Le Leu, M.B. Van der Hoek, M.Z. Michael, Histone
deacetylase inhibition in colorectal cancer cells reveals competing roles for mem-
bers of the oncogenic miR-17-92 cluster, Mol. Carcinog. 52 (2013) 459–474.
[14] V. Carafa, A. Nebbioso, L. Altucci, Histone deacetylase inhibitors: recent insights from
basic to clinical knowledge & patenting of anti-cancer actions, Recent Pat. Antican-
cer Drug Discov. 6 (2011) 131–145.
[15] J. Kanwar, M. Taskeen, I. Mohammad, C. Huo, T.H. Chan, Q.P. Dou, Recent advances
on tea polyphenols, Front. Biosci. (Elite Ed.) 4 (2012) 111–131.
[16] C.S. Yang, X. Wang, Green tea and cancer prevention, Nutr. Cancer 62 (2010)
931–937.
[17] S. Balasubramanian, R.L. Ecker, Keratinocyte proliferation, differentiation, and
apoptosis—differential mechanisms of regulation by curcumin, EGCG and apigenin,
Toxicol. Appl. Pharmacol. 224 (2007) 214–219.
[18] S. Lamy, D. Gingras, R. Beliveau, Green tea catechins inhibit vascular endothelial
growth factor receptor phosphorylation, Cancer Res. 62 (2002) 381–385.
[19] Y. Oka, S. Iwai, H. Amano, Y. Irie, K. Yatomi, K. Ryu, S. Yamada, K. Inagaki, K. Oguchi,
Tea polyphenols inhibit rat osteoclast formation and differentiation, J. Pharmacol.
Sci. 118 (2012) 55–64.
[20] M.A. Lea, C. Ibeh, L. Han, C. Desbordes, Inhibition of growth and induction of differ-
entiation markers by polyphenolic molecules and histone deacetylase inhibitors in
colon cancer cells, Anticancer Res. 30 (2010) 311–318.
[21] P. Gonçalves, J.R. Araujo, M.J. Pinho, F. Martel, In vitro studies on the inhibition of
colon cancer by butyrate and polyphenolic compounds, Nutr. Cancer 63 (2011)
282–294.
[22] M.P.Moyer, L.A.Manzano, R.L. Merriman, J.S. Stauffer, L.R. Tanzer, NCM460, a normal
human colon mucosal epithelial cell line, In Vitro Cell. Dev. Biol. 32 (1996) 315–317.
[23] S. Sanchez-Tena, M.L. Fernandez-Cachon, A. Carreras, M.L. Mateos-Martin, N.
Costoya, M.P. Moyer, M.J. Nunez, J.L. Torres, M. Cascante, Hamamelitannin from
witch hazel (Hamamelis virginiana) displays speciﬁc cytotoxic activity against
colon cancer cells, J. Nat. Prod. 75 (2012) 26–33.
[24] H.U. Bergmeyer, Standardization of enzyme assays, Clin. Chem. 18 (1972) 1305–1311.[25] Y. Qiu, Y. Wang, P.Y. Law, H.Z. Chen, H.H. Loh, Cholesterol regulates micro-opioid
receptor-induced beta-arrestin 2 translocation to membrane lipid rafts, Mol.
Pharmacol. 80 (2011) 210–218.
[26] F. Zhao, J. Zhang, Y.S. Liu, L. Li, Y.L. He, Research advances on ﬂotillins, Virol. J. 8
(2011) 479.
[27] M. Waldecker, T. Kautenburger, H. Daumann, S. Veeriah, F. Will, H. Dietrich, B.L.
Pool-Zobel, D. Schrenk, Histone-deacetylase inhibition and butyrate formation:
fecal slurry incubations with apple pectin and apple juice extracts, Nutrition
(Burbank Los Angeles County, Calif) 24 (2008) 366–374.
[28] S. Saksena, S. Theegala, N. Bansal, R.K. Gill, S. Tyagi, W.A. Alrefai, K. Ramaswamy, P.K.
Dudeja, Mechanisms underlying modulation of monocarboxylate transporter 1
(MCT1) by somatostatin in human intestinal epithelial cells, Am. J. Physiol. 297
(2009) G878–G885.
[29] D. Colin, E. Limagne, S. Jeanningros, A. Jacquel, G. Lizard, A. Athias, P. Gambert, A.
Hichami, N. Latruffe, E. Solary, D. Delmas, Endocytosis of resveratrol via lipid rafts
and activation of downstream signaling pathways in cancer cells, Cancer Prev. Res.
(Phila.) 4 (2011) 1095–1106.
[30] M. Waldecker, T. Kautenburger, H. Daumann, C. Busch, D. Schrenk, Inhibition of
histone-deacetylase activity by short-chain fatty acids and some polyphenol metab-
olites formed in the colon, J. Nutr. Biochem. 19 (2008) 587–593.
[31] S. Nair, V. Hebbar, G. Shen, A. Gopalakrishnan, T.O. Khor, S. Yu, C. Xu, A.N. Kong,
Synergistic effects of a combination of dietary factors sulforaphane and (−)
epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells, Pharm.
Res. 25 (2008) 387–399.
[32] N.D. Amoedo, M.F. Rodrigues, P. Pezzuto, A. Galina, R.M. da Costa, F.C. de Almeida, T.
El-Bacha, F.D. Rumjanek, Energy metabolism in H460 lung cancer cells: effects of
histone deacetylase inhibitors, PLoS One 6 (2011) e22264.
[33] P. Gonçalves, J.R. Araujo, F. Martel, Characterization of butyrate uptake by
nontransformed intestinal epithelial cell lines, J. Membr. Biol. 240 (2011) 35–46.
[34] A. Borthakur, A.N. Anbazhagan, A. Kumar, G. Raheja, V. Singh, K. Ramaswamy, P.K.
Dudeja, The probiotic Lactobacillus plantarum counteracts TNF-{alpha}-induced
downregulation of SMCT1 expression and function, Am. J. Physiol. 299 (2010)
G928–G934.
[35] Y. Konishi, S. Kobayashi, M. Shimizu, Tea polyphenols inhibit the transport of dietary
phenolic acidsmediated by themonocarboxylic acid transporter (MCT) in intestinal
Caco-2 cell monolayers, J. Agric. Food Chem. 51 (2003) 7296–7302.
[36] C.K. Shim, E.P. Cheon, K.W. Kang, K.S. Seo, H.K. Han, Inhibition effect of ﬂavonoids on
monocarboxylate transporter 1 (MCT1) in Caco-2 cells, J. Pharm. Pharmacol. 59
(2007) 1515–1519.
[37] J.B. Vaidyanathan, T. Walle, Cellular uptake and efﬂux of the tea ﬂavonoid (−)
epicatechin-3-gallate in the human intestinal cell line Caco-2, J. Pharmacol. Exp.
Ther. 307 (2003) 745–752.
[38] Q. Wang, M.E. Morris, Flavonoids modulate monocarboxylate transporter-1-
mediated transport of gamma-hydroxybutyrate in vitro and in vivo, Drug Metab.
Dispos. 35 (2007) 201–208.
[39] M.A. Cuff, D.W. Lambert, S.P. Shirazi-Beechey, Substrate-induced regulation of the
human colonic monocarboxylate transporter, MCT1, J. Physiol. 539 (2002) 361–371.
[40] A. Borthakur, S. Saksena, R.K. Gill, W.A. Alrefai, K. Ramaswamy, P.K. Dudeja, Regula-
tion of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human in-
testinal epithelial cells: involvement of NF-kappaB pathway, J. Cell. Biochem. 103
(2008) 1452–1463.
[41] G. Chen, A.G. Howe, G. Xu, O. Frohlich, J.D. Klein, J.M. Sands, Mature N-linked glycans
facilitate UT-A1 urea transporter lipid raft compartmentalization, FASEB J. 25 (2011)
4531–4539.
[42] S.K. Patra, F. Rizzi, A. Silva, D.O. Rugina, S. Bettuzzi, Molecular targets of
(−)-epigallocatechin-3-gallate (EGCG): speciﬁcity and interaction with mem-
brane lipid rafts, J. Physiol. Pharmacol. 59 (Suppl. 9) (2008) 217–235.
[43] D. Duhon, R.L. Bigelow, D.T. Coleman, J.J. Steffan, C. Yu, W. Langston, C.G. Kevil, J.A.
Cardelli, The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activa-
tion of the c-Met receptor in prostate cancer cells, Mol. Carcinog. 49 (2010)
739–749.
[44] S. Adachi, T. Nagao, H.I. Ingolfsson, F.R. Maxﬁeld, O.S. Andersen, L. Kopelovich, I.B.
Weinstein, The inhibitory effect of (−)-epigallocatechin gallate on activation of
the epidermal growth factor receptor is associated with altered lipid order in
HT29 colon cancer cells, Cancer Res. 67 (2007) 6493–6501.
[45] C.S. Yang, J.D. Lambert, S. Sang, Antioxidative and anti-carcinogenic activities of tea
polyphenols, Arch. Toxicol. 83 (2009) 11–21.
[46] H.I. Ingolfsson, R.E. Koeppe II, O.S. Andersen, Effects of green tea catechins on gram-
icidin channel function and inferred changes in bilayer properties, FEBS Lett. 585
(2011) 3101–3105.
